Cue Biopharma is trading at $28.57, down -6.33%, amid broader risk-off sentiment after hotter-than-expected August PPI lifted Treasury yields and pressured equities.

  • No clear company-specific announcement dated September 10, 2026 was identified; Cue Biopharma’s listed updates predate the session.
  • The S&P 500, Nasdaq Composite, and Dow Jones were each down more than 0.5% during trading.